More than 1 in 10 U.S. adults is currently taking a GLP-1 weight-loss drug. And these medicines are getting cheaper seemingly by the day.

Since Wegovy launched, its list price has fallen from roughly $1,300 per month to between $300 and $500 per month. Similarly, Zepbound was once about $1,000 per month, but it now costs about $350. The cash prices, for patients not paying with insurance, are even lower.

Recommended Stories

Treatment for millions of Americans at stake in ‘skinny label’ Supreme Court case

Insurers want you to hate drugmakers so you won’t notice who’s actually robbing you

Big Tech’s patent battering ram isn’t lowering drug prices